Home ETF List About

ETF Holdings Breakdown of PODD

Stock NameInsulet Corporation
TickerPODD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45784P1012
LEI549300TZTYD2PYN92D43

PODD institutional holdings

The adjusted close for PODD on 2025-11-11 was 326.28

The following institutional investment holdings of PODD have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-11 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 167,826USD 54,758,267 1.8% 326.28  
2025-11-11 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 167,826USD 54,758,267 1.8% 326.28  
2025-11-11 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 167,826USD 54,758,267 1.8% 326.28  
2025-11-11 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 101,404USD 33,086,097 1.8% 326.28  
2025-11-11 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 101,404USD 33,086,097 326.28  
2025-11-11 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 101,404USD 33,086,097 1.8% 326.28  
2025-11-11 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 101,404USD 33,086,097 1.8% 326.28  
2025-11-11 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 24,852USD 8,108,711 326.28  
2025-11-11 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 18,279 0.0%USD 5,964,072 1.9% 326.28  
2025-11-11 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 36,142USD 11,792,412 326.28  
2025-11-11 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 36,142USD 11,792,412 326.28  
2025-11-11 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 36,142USD 11,792,412 1.8% 326.28  
2025-11-11 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 20,855USD 6,804,569 326.28  
2025-11-11 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 20,855USD 6,804,569 326.28  
2025-11-11 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 20,855USD 6,804,569 326.28  
2025-11-11 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 53,916 200.0%USD 17,591,712 198.2% 326.28  
2025-11-11 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 53,916 200.0%USD 17,591,712 198.2% 326.28  
2025-11-11 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 8,400 -0.4%USD 2,740,752 1.4% 326.28  
2025-11-11 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 20,320USD 6,630,010 1.8% 326.28  
2025-11-11 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 20,320USD 6,630,010 326.28  
2025-11-11 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 20,320USD 6,630,010 1.8% 326.28  
2025-11-11 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 20,320USD 6,630,010 1.8% 326.28  
2025-11-11 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 10,532USD 2,963,675 1.4% 281.40 Incorrect share price reported. Should be 326.28 not 281.40. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 3,019USD 985,039 326.28  
2025-11-07 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 5,693USD 1,820,735 -1.1% 319.82 Incorrect share price reported. Should be 326.28 not 319.82. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 22,633 -0.1%USD 7,384,695 1.7% 326.28  
2025-11-11 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 22,633USD 7,384,695 326.28  
2025-11-11 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 4,304 -1.0%USD 1,211,133 0.8% 281.40 Incorrect share price reported. Should be 326.28 not 281.40. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 34,884USD 11,381,952 326.28  
2025-11-11 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 34,884USD 11,381,952 1.8% 326.28  
2025-11-11 IE00BP3QZ825 (iShares Edge MSCI World Momentum Factor UCITS ETF) 7,961USD 2,597,515 326.28  
2025-11-11 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 2,991USD 975,903 1.8% 326.28  
2025-11-11 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 1,452USD 473,759 326.28  
2025-11-11 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 50,136USD 16,358,374 326.28  
2025-11-11 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 1,401USD 457,118 326.28  
2025-11-11 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 1,401USD 457,118 326.28  
2025-11-10 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 1,730USD 421,497 0.2% 243.64 Incorrect share price reported. Should be 326.28 not 243.64. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B3Y8X563 incorrectly reporting value of holding as USD actually is reported in GBP
2025-11-11 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 420USD 137,038 1.8% 326.28  
2025-11-11 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 420USD 137,038 1.8% 326.28  
2025-11-11 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 496USD 122,821 1.6% 247.62 Incorrect share price reported. Should be 326.28 not 247.62. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 1,438USD 469,191 326.28  
2025-11-11 IE00BMX0DF60 (iShares US Medical Devices UCITS ETF) 9,810USD 3,200,807 1.8% 326.28  
2025-11-11 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 2,795USD 911,953 1.8% 326.28  
2025-11-11 IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF) 1,130USD 368,696 1.8% 326.28  
2025-11-11 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 404USD 131,817 1.8% 326.28  
2025-11-11 IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc) 266USD 86,790 326.28  
2025-11-11 IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc) 33USD 10,767 326.27 Incorrect share price reported. Should be 326.28 not 326.27. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 1,489USD 485,831 1.8% 326.28  
2025-11-11 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 32,806USD 10,703,942 326.28  
2025-11-10 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 18,279USD 5,855,678 0.2% 320.35 Incorrect share price reported. Should be 326.28 not 320.35. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-10 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 3,019 0.5%USD 967,137 -0.5% 320.35 Incorrect share price reported. Should be 326.28 not 320.35. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 5,693USD 1,857,512 1.8% 326.28  
Total =1,604,880 USD 522,629,309
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with PODD

Insulet (NASDAQ:PODD) Price Target Raised to $360.00 at Piper Sandler
Insulet (NASDAQ:PODD – Free Report) had its price target upped by Piper Sandler from $320.00 to $360.00 in a research report report published on Tuesday,MarketScreener reports. Piper Sandler currently has an overweight rating on the medical instruments supplier’s stock. A number of other research firms have also recently issued reports on PODD. Citigroup reiterated a […] - 2025-09-19 02:18:57
Insulet (NASDAQ:PODD) Trading Down 5% on Insider Selling
Insulet Corporation (NASDAQ:PODD – Get Free Report) was down 5% during mid-day trading on Wednesday after an insider sold shares in the company. The stock traded as low as $330.00 and last traded at $335.01. Approximately 171,562 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 747,968 shares. […] - 2025-09-11 02:33:48
Insulet (NASDAQ:PODD) Reaches New 52-Week High After Analyst Upgrade
Insulet Corporation (NASDAQ:PODD – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday after Oppenheimer raised their price target on the stock from $324.00 to $365.00. Oppenheimer currently has an outperform rating on the stock. Insulet traded as high as $350.00 and last traded at $346.70, with a volume […] - 2025-09-10 02:26:53
Insulet (NASDAQ:PODD) Price Target Raised to $350.00
Insulet (NASDAQ:PODD – Free Report) had its target price lifted by Wells Fargo & Company from $330.00 to $350.00 in a research note published on Friday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the medical instruments supplier’s stock. PODD has been the topic of several other reports. Oppenheimer increased their […] - 2025-08-11 05:21:01
Insulet (NASDAQ:PODD) Price Target Raised to $353.00 at Canaccord Genuity Group
Insulet (NASDAQ:PODD – Free Report) had its price target boosted by Canaccord Genuity Group from $331.00 to $353.00 in a report released on Friday,Benzinga reports. The firm currently has a buy rating on the medical instruments supplier’s stock. Other research analysts have also recently issued reports about the stock. Jefferies Financial Group reiterated a “buy” […] - 2025-08-11 05:20:57
Royal Bank Of Canada Raises Insulet (NASDAQ:PODD) Price Target to $350.00
Insulet (NASDAQ:PODD – Free Report) had its price target hoisted by Royal Bank Of Canada from $330.00 to $350.00 in a report issued on Friday,Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock. Other research analysts have also recently issued reports about the company. Sanford C. Bernstein reissued an “outperform” […] - 2025-08-11 02:14:43
Brokerages Set Insulet Corporation (NASDAQ:PODD) Target Price at $321.00
Shares of Insulet Corporation (NASDAQ:PODD – Get Free Report) have received an average rating of “Moderate Buy” from the eighteen brokerages that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average twelve-month price target […] - 2025-08-04 02:43:02
Choreo LLC Sells 57 Shares of Insulet Corporation (NASDAQ:PODD)
Choreo LLC decreased its position in shares of Insulet Corporation (NASDAQ:PODD – Free Report) by 2.5% in the 1st quarter, Holdings Channel reports. The fund owned 2,182 shares of the medical instruments supplier’s stock after selling 57 shares during the quarter. Choreo LLC’s holdings in Insulet were worth $573,000 as of its most recent filing […] - 2025-07-28 05:46:53
GW&K Investment Management LLC Buys 133 Shares of Insulet Corporation (NASDAQ:PODD)
GW&K Investment Management LLC increased its position in shares of Insulet Corporation (NASDAQ:PODD – Free Report) by 114.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 249 shares of the medical instruments supplier’s stock after buying an additional 133 shares during […] - 2025-07-24 06:12:50
Cwm LLC Increases Stock Position in Insulet Corporation (NASDAQ:PODD)
Cwm LLC raised its position in Insulet Corporation (NASDAQ:PODD – Free Report) by 1.6% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 4,034 shares of the medical instruments supplier’s stock after purchasing an additional 64 shares during the period. Cwm LLC’s holdings in Insulet were worth $1,059,000 as of its most recent SEC […] - 2025-07-22 07:17:22
Nisa Investment Advisors LLC Buys 3,057 Shares of Insulet Corporation (NASDAQ:PODD)
Nisa Investment Advisors LLC increased its stake in shares of Insulet Corporation (NASDAQ:PODD – Free Report) by 69.7% during the first quarter, HoldingsChannel.com reports. The fund owned 7,445 shares of the medical instruments supplier’s stock after purchasing an additional 3,057 shares during the period. Nisa Investment Advisors LLC’s holdings in Insulet were worth $1,955,000 as […] - 2025-07-14 06:32:53
Bank of New York Mellon Corp Has $116 Million Position in Insulet Corporation (NASDAQ:PODD)
Bank of New York Mellon Corp reduced its stake in Insulet Corporation (NASDAQ:PODD – Free Report) by 1.7% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 441,723 shares of the medical instruments supplier’s stock after selling 7,648 shares during the quarter. Bank of New […] - 2025-07-10 06:20:47
Analysts Set Insulet Corporation (NASDAQ:PODD) Price Target at $321.00
Shares of Insulet Corporation (NASDAQ:PODD – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eighteen ratings firms that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average 12 […] - 2025-07-10 02:50:51
Amalgamated Bank Boosts Stake in Insulet Corporation (NASDAQ:PODD)
Amalgamated Bank increased its stake in shares of Insulet Corporation (NASDAQ:PODD – Free Report) by 2.5% in the first quarter, HoldingsChannel.com reports. The firm owned 14,909 shares of the medical instruments supplier’s stock after buying an additional 361 shares during the period. Amalgamated Bank’s holdings in Insulet were worth $3,915,000 at the end of the […] - 2025-07-04 05:24:52
Insulet Corporation (NASDAQ:PODD) Shares Sold by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC decreased its stake in Insulet Corporation (NASDAQ:PODD – Free Report) by 9.1% in the 1st quarter, Holdings Channel reports. The firm owned 1,972 shares of the medical instruments supplier’s stock after selling 198 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Insulet were worth $518,000 at the end of […] - 2025-07-03 04:58:51
Wealth Enhancement Advisory Services LLC Purchases 370 Shares of Insulet Corporation (NASDAQ:PODD)
Wealth Enhancement Advisory Services LLC boosted its position in Insulet Corporation (NASDAQ:PODD – Free Report) by 13.9% during the first quarter, Holdings Channel reports. The institutional investor owned 3,028 shares of the medical instruments supplier’s stock after purchasing an additional 370 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Insulet were worth […] - 2025-07-03 04:26:56
Insulet Corporation (NASDAQ:PODD) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. lowered its stake in shares of Insulet Corporation (NASDAQ:PODD – Free Report) by 13.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 14,240 shares of the medical instruments supplier’s stock after selling 2,179 shares during the period. Mirae Asset Global […] - 2025-07-02 05:34:54
Kentucky Retirement Systems Insurance Trust Fund Invests $533,000 in Insulet Corporation (NASDAQ:PODD)
Kentucky Retirement Systems Insurance Trust Fund acquired a new position in shares of Insulet Corporation (NASDAQ:PODD – Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 2,031 shares of the medical instruments supplier’s stock, valued at approximately $533,000. Other institutional investors have also modified their holdings […] - 2025-06-25 05:28:59
Sagespring Wealth Partners LLC Acquires 122 Shares of Insulet Corporation (NASDAQ:PODD)
Sagespring Wealth Partners LLC lifted its holdings in Insulet Corporation (NASDAQ:PODD – Free Report) by 13.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,024 shares of the medical instruments supplier’s stock after buying an additional 122 shares during the […] - 2025-06-20 05:32:53
Insulet (NASDAQ:PODD) Coverage Initiated by Analysts at Truist Financial
Analysts at Truist Financial initiated coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $365.00 price target on the medical instruments supplier’s stock. Truist Financial’s price target suggests a potential upside of 19.91% from the company’s previous […] - 2025-06-18 02:57:00
OLD National Bancorp IN Increases Stock Position in Insulet Co. (NASDAQ:PODD)
OLD National Bancorp IN raised its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 6.7% during the first quarter, Holdings Channel.com reports. The firm owned 880 shares of the medical instruments supplier’s stock after purchasing an additional 55 shares during the quarter. OLD National Bancorp IN’s holdings in Insulet were worth $231,000 as of […] - 2025-06-11 06:38:48
Wedmont Private Capital Acquires 374 Shares of Insulet Co. (NASDAQ:PODD)
Wedmont Private Capital boosted its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 26.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 1,804 shares of the medical instruments supplier’s stock after purchasing an additional 374 shares during the quarter. Wedmont Private Capital’s holdings in Insulet were worth $458,000 as of […] - 2025-06-11 05:26:56
QGRO, TJX, HWM, PODD: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the American Century U.S. Quality Growth ETF (Symbol: QGRO) where we have detected an approximate $139.4 million dollar inflow -- that's a 9.0% increase - 2025-06-03 12:36:20
S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF
SPY jumped 6.3% in May, the most in decades, led by standout gains in NRG, STX, CEG, PODD and MCHP amid easing trade fears. - 2025-06-03 12:30:00
Raymond James Issues Positive Forecast for Insulet (NASDAQ:PODD) Stock Price
Insulet (NASDAQ:PODD – Get Free Report) had its price target upped by investment analysts at Raymond James from $328.00 to $360.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Raymond James’ price objective would suggest a potential upside of 11.27% from the stock’s […] - 2025-05-29 02:36:48
Insulet Co. (NASDAQ:PODD) Shares Bought by Janus Henderson Group PLC
Janus Henderson Group PLC boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 7.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,846 shares of the medical instruments supplier’s stock after purchasing an additional 511 shares during the quarter. Janus Henderson Group PLC’s holdings in Insulet were worth $2,049,000 […] - 2025-05-22 04:54:45
Insulet (NASDAQ:PODD) Upgraded at Wolfe Research
Wolfe Research upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a peer perform rating to an outperform rating in a research note published on Tuesday morning, MarketBeat reports. The firm currently has $350.00 target price on the medical instruments supplier’s stock. A number of other research analysts have also recently commented on PODD. Canaccord […] - 2025-05-16 04:40:55
PODD Crosses Above Average Analyst Target
In recent trading, shares of Insulet Corp (Symbol: PODD) have crossed above the average analyst 12-month target price of $320.60, changing hands for $321.41/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua - 2025-05-15 10:14:13
Insulet (NASDAQ:PODD) Downgraded to Peer Perform Rating by Wolfe Research
Wolfe Research cut shares of Insulet (NASDAQ:PODD – Free Report) from an outperform rating to a peer perform rating in a research note released on Tuesday, MarketBeat.com reports. Other equities research analysts also recently issued research reports about the company. Royal Bank of Canada started coverage on Insulet in a report on Thursday, March 6th. […] - 2025-05-02 02:54:51
Insulet Co. (NASDAQ:PODD) Sees Significant Decrease in Short Interest
Insulet Co. (NASDAQ:PODD – Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 2,400,000 shares, a decrease of 16.7% from the March 15th total of 2,880,000 shares. Based on an average trading volume of 775,100 shares, the […] - 2025-04-21 03:15:00

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.